Synthetic peptide reference material
Retatrutide 10 mg
Retatrutide 10 mg synthetic peptide reference material supplied as one labeled research vial with lot-focused documentation.
Scientific background
Retatrutide (LY3437943) is an investigational peptide that activates three metabolic signaling receptors: GIP, GLP-1, and glucagon. It has been studied in clinical trials, but it is not FDA approved and its safety and effectiveness are still being evaluated.
In plain language
Researchers are studying one molecule that can signal through three different pathways involved in metabolism. This vial is a laboratory reference material, not an approved medicine or a product for personal treatment.